Vision Source
Kansas City, Missouri, 64111, United States
Location status: Recruiting
Location contact
Crystal Remington Remington, OD
CONTACT
Ryan Powell Powell, OD
CONTACT
NCT Number: NCT06965426
To compare skin carotenoid scores over 12 weeks of individuals randomized to placebo or MacuHealth and comparing that to a 12 week crossover evaluation.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Kansas City, Missouri, 64111, United States
Location status: Recruiting
Crystal Remington Remington, OD
CONTACT
Ryan Powell Powell, OD
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
Other names: MacuHealth
Time frame: 6 months
Change in skin carotenoid concentration over supplementation vs. placebo exposure durations.
Contact information is provided by the study sponsor or research team.
Crystal Remington, OD
CONTACT
Ryan Powell, OD
CONTACT
Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03167203
Macular Degenerative Disease
Kansas City, Missouri, United States
View Trial DetailsNCT01496625
Abnormalities, Multiple, Age-Related Macular Degeneration
Bethesda, Maryland, United States
View Trial DetailsNCT04697095
Age Related Macular Degeneration, Eye Diseases
Lyon, France
View Trial DetailsNCT03178149
Age-Related Macular Degeneration, Eye Diseases
Phoenix, Arizona, United States
View Trial Details